NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases-Reference-Cited by-同舟云学术

NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases

Published:2019-03 Issue: Volume:80 Page:147-152
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Binh Mai Thanh,Hoan Nghiem Xuan^ORCID,Van Tong Hoang,Sy Bui Tien,Trung Ngo Tat,Bock C.-Thomas,Toan Nguyen Linh,Song Le Huu,Bang Mai Hong,Meyer Christian G.,Kremsner Peter G.,Velavan Thirumalaisamy P.^ORCID

Funder

DAAD-PAGEL

Federal Ministry of Education and Research

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference32 articles.

1. Systematic review: the model for end-stage liver disease—should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis?;Cholongitas;Aliment Pharmacol Ther,2005

2. The solute carrier family 10 (SLC10): beyond bile acid transport;Claro da Silva;Mol Aspects Med,2013

3. Treatment of hepatocellular carcinoma;Diaz-Gonzalez;Dig Dis,2016

4. Lack of Ser267Phe variant of sodium taurocholate cotransporting polypeptide among Moroccans regardless of hepatitis B virus infection status;Ezzikouri;BMC Infect Dis,2017

5. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas;Faubion;J Clin Invest,1999

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC10A1 rs2296651 variant (S267F mutation) predicts biochemical traits, hepatitis B virus infection susceptibility and the risk of gallstone disease;Molecular Genetics and Genomics;2024-06-13

2. Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation;The American Journal of Human Genetics;2024-06

3. Hepatitis B virus genotypes in precision medicine of hepatitis B-related hepatocellular carcinoma: Where we are now;World Journal of Gastrointestinal Oncology;2024-04-15

4. Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP;Nature Communications;2024-03-20

5. Structure of hepatitis B/D antiviral drug Bulevirtide bound to its receptor protein NTCP;2024-01-22